Exact Sciences Files 10-K, Details 2023 Financials

TL;DR

**EXAS just dropped its 10-K, giving us the full financial picture through 2023!**

AI Summary

EXACT SCIENCES CORP (EXAS) filed its 10-K on February 21, 2024, for the fiscal year ending December 31, 2023. The company, a medical laboratories service provider based in Madison, WI, reported its financial performance for 2023, 2022, and 2021. Key financial data points include common stock, additional paid-in capital, accumulated other comprehensive income, and retained earnings as of December 31, 2020, and subsequent changes through 2023.

Why It Matters

This filing provides a comprehensive look into Exact Sciences' financial health and operational performance, crucial for investors to assess its stability and future growth prospects in the medical diagnostics industry.

Risk Assessment

Risk Level: medium — The filing itself doesn't detail specific risks, but as a medical laboratory company, it faces inherent risks related to regulatory changes, competition, and product development.

Key Numbers

• 2023-12-31 — Conformed Period of Report (The fiscal year-end covered by this 10-K filing.)
• 2024-02-21 — Filed As Of Date (The date the 10-K was officially filed with the SEC.)
• 001-35092 — SEC File Number (Unique identifier for the company's SEC filings.)
• 133 — Public Document Count (Number of documents included in the filing.)
• 8071 — SIC Code (Standard Industrial Classification for Medical Laboratories.)

Key Players & Entities

• EXACT SCIENCES CORP (company) — filer of the 10-K
• 0001124140 (company) — Central Index Key (CIK) for EXACT SCIENCES CORP
• Madison, WI (location) — business address of EXACT SCIENCES CORP
• 2023-12-31 (date) — Conformed Period of Report end date
• 2024-02-21 (date) — Filed As Of Date
• 2020-12-31 (date) — balance sheet date for initial equity components

FAQ

From the Filing

0001124140-24-000012.txt : 20240221 0001124140-24-000012.hdr.sgml : 20240221 20240221170528 ACCESSION NUMBER: 0001124140-24-000012 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 133 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240221 DATE AS OF CHANGE: 20240221 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EXACT SCIENCES CORP CENTRAL INDEX KEY: 0001124140 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 204782291 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35092 FILM NUMBER: 24660807 BUSINESS ADDRESS: STREET 1: 5505 ENDEAVOR LANE CITY: MADISON STATE: WI ZIP: 53719 BUSINESS PHONE: 608-284-5700 MAIL ADDRESS: STREET 1: 5505 ENDEAVOR LANE CITY: MADISON STATE: WI ZIP: 53719 FORMER COMPANY: FORMER CONFORMED NAME: EXACT CORP DATE OF NAME CHANGE: 20000919 10-K 1 exas-20231231.htm 10-K exas-20231231 0001124140 FALSE 2023 FY P3Y P3Y http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#OtherOperatingIncomeExpenseNet 0001124140 2023-01-01 2023-12-31 0001124140 2023-06-30 iso4217:USD 0001124140 2024-02-21 xbrli:shares 0001124140 2023-12-31 0001124140 2022-12-31 iso4217:USD xbrli:shares 0001124140 2022-01-01 2022-12-31 0001124140 2021-01-01 2021-12-31 0001124140 us-gaap:CommonStockMember 2020-12-31 0001124140 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001124140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001124140 us-gaap:RetainedEarningsMember 2020-12-31 0001124140 2020-12-31 0001124140 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001124140 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001124140 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001124140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001124140 us-gaap:CommonStockMember 2021-12-31 0001124140 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001124140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001124140 us-gaap:RetainedEarningsMember 2021-12-31 0001124140 2021-12-31 0001124140 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001124140 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001124140 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001124140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001124140 us-gaap:CommonStockMember 2022-12-31 0001124140 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001124140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001124140 us-gaap:RetainedEarningsMember 2022-12-31 0001124140 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001124140 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001124140 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001124140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-12-31 0001124140 us-gaap:CommonStockMember 2023-12-31 0001124140 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001124140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001124140 us-gaap:RetainedEarningsMember 2023-12-31 0001124140 us-gaap:ConvertibleNotesPayableMember 2023-01-01 2023-12-31 0001124140 us-gaap:ConvertibleNotesPayableMember 2022-01-01 2022-12-31 0001124140 us-gaap:ConvertibleNotesPayableMember 2021-01-01 2021-12-31 0001124140 us-gaap:RestrictedStockMember 2023-01-01 2023-12-31 0001124140 us-gaap:RestrictedStockMember 2022-01-01 2022-12-31 0001124140 us-gaap:RestrictedStockMember 2021-01-01 2021-12-31 0001124140 us-gaap:PerformanceSharesMember 2023-01-01 2023-12-31 0001124140 us-gaap:PerformanceSharesMember 2022-01-01 2022-12-31 0001124140 us-gaap:P